Castellum AB (0GT1)
London Exchange · UK · prices in SEK · close of 16 Oct 2026
Key indicators
| Last close | SEK 125.75 |
|---|---|
| 52-week range | 100.30 – 137.23 |
| Return, 1 month / 3 months | −1.7% / −3.6% |
| Return, 1 year / 3 years | +14.0% / +24.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 53 |
| Volatility (1 year) | 23.0% |
| Worst drawdown (1 year) | -13.8% |
| Average daily value traded | 30.85M SEK |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Castellum AB is a Swedish property company that owns and manages commercial real estate, with a focus on office premises. Its portfolio also includes logistics and warehouse space, retail properties and public-sector buildings such as schools and care facilities. The company rents space to businesses and organisations, mainly in Swedish cities and growth regions, and handles the management and development of its buildings. It is based in Gothenburg.
On this site Castellum AB appears as a stock on the London Exchange (UK), code 0GT1, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Castellum AB (0GT1) trades on the London Exchange in UK. It last closed at SEK 125.75 on 16 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 907 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.0% and over the last three months it fell 3.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.6% | ||
| From 52-week high | -8.3% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.6% | ||
| 6-month return | -0.1% | ||
| 12-month return, skipping the last month | 15.9% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.8% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 30.85M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 21 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.9% |
|---|---|
| 1 month | −1.7% |
| 3 months | −3.6% |
| 6 months | −0.1% |
| 1 year | +14.0% |
| 3 years | +24.1% |
| 5 years | −28.2% |
Signals
| 50-day / 200-day average | 129.15 / 121.41 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | SEK 0.6200 |
| 29 Sep 2025 | SEK 0.6200 |
| 27 Jun 2025 | SEK 0.6200 |
| 8 May 2025 | SEK 0.6200 |
| 29 Dec 2022 | SEK 1.9000 |
| 29 Sep 2022 | SEK 1.9000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.